Literature DB >> 31414733

Gastrointestinal non-Hodgkin lymphomas.

Magdalena Olszewska-Szopa1, Tomasz Wróbel1.   

Abstract

Although gastrointestinal (GI) tract is the most common extranodal site involved in non-Hodgkin lymphoma (NHL), primary gastrointestinal NHL (gNHL) is a rare problem which concerns about 10-15% of NHL patients and 30-40% of extranodal NHL patients. Lymphoid neoplasms may consist of mature B, T and (less commonly) extranodal NK/T cells. The most common diagnoses are diffuse large B-cell lymphoma and marginal zone lymphoma (MALT), but many other lymphomas may be found in the GI tract. There are a few well-known risk factors of gNHL and some of them affect treatment. The most frequent sites of occurrence are the stomach followed by small intestine and ileocecal region. In the last 2 decades, there has been a rapid development in the diagnosis, staging and management of GI lymphoma, but still some of such lymphomas, especially T-cell ones, are a therapeutic challenge. In this review, we present clinical and pathological features of GI lymphomas. We also describe the current status in diagnosis and treatment.

Entities:  

Keywords:  DLBCL; EATL; MALT; gastrointestinal lymphoma

Mesh:

Year:  2019        PMID: 31414733     DOI: 10.17219/acem/94068

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  12 in total

Review 1.  Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.

Authors:  Vetri Sudar Jayaprakasam; Viktoriya Paroder; Heiko Schöder
Journal:  Semin Nucl Med       Date:  2021-05-06       Impact factor: 4.802

2.  Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.

Authors:  Jing Wang; Min Zhou; Rongfu Zhou; Jingyan Xu; Bing Chen
Journal:  Front Oncol       Date:  2020-07-03       Impact factor: 6.244

3.  Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: a comparison of treatment outcomes.

Authors:  Shigenobu Watanabe; Ichiro Ogino; Masaharu Hata
Journal:  Blood Res       Date:  2020-12-31

4.  Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas.

Authors:  Cuifen Zhang; Zeyu Liu; Jiahao Tao; Lizhu Lin; Linzhu Zhai
Journal:  Cancer Manag Res       Date:  2021-12-20       Impact factor: 3.989

5.  Surgery plus chemotherapy versus chemotherapy alone in primary intestinal lymphoma: a meta-analysis.

Authors:  Yefei Shu; Xiaofeng Xu; Wei Yang; Ling Xu
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

6.  Colo-enteric fistula associated with diffuse large B cell lymphoma that resulted in gastrointestinal bleeding: A case report and literature review.

Authors:  Shih-Wei Chiang; Tzu-Wei Chiang
Journal:  Int J Surg Case Rep       Date:  2022-01-31

7.  Analysis of 78 Cases of Primary Gastrointestinal Lymphoma.

Authors:  Yu Xiang; Lidi Yao
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

8.  Radiotherapeutic Outcomes for Localized Primary Rectal Mucosa-Associated Lymphoid Tissue Lymphoma: A Consecutive Case Series of Three Patients.

Authors:  Atsuto Katano; Kenta Takeuchi; Hideomi Yamashita
Journal:  Cureus       Date:  2022-02-16

9.  Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient.

Authors:  Akriti Pokhrel; Orzu Yuldasheva; Elidona Mirashi; Kiron Nair; Muhammad Salyana; Vijay Jaswani; Boris Avezbakiyev; Jen C Wang
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

10.  A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.

Authors:  Junmin Wang; Weirui Ren; Chuang Zhang; Xiaoya Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.